Therapeutic potential of endothelin receptor antagonists in diabetes

Author： Chakrabarti S.   Cukiernik M.   Mukherjee S.   Chen S.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.12, 2000-12, pp. : 2873-2888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E.   Noll G.   Lüscher T.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

By Tilton Ronald G   Brock Tommy A   Dixon Richard AF  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1291-1308

Informa Healthcare

Access to resources Recommend Favorite

The renoprotective potential of endothelin receptor antagonists

By Benigni A.   Remuzzi G.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 2, 1997-02 ,pp. : 139-149

Informa Healthcare

Access to resources Recommend Favorite

The renoprotective potential of endothelin receptor antagonists

By Knoll T.   Schaub M.   Birck R.   Braun C.   Juenemann K-P.   Rohmeiss P.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 1041-1052

Informa Healthcare

Access to resources Recommend Favorite